Thérapie génique de l'adrénoleucodystrophie

Archives de Pediatrie

Volumn 3, Issue SUPPL. 1, 1996, Pages

  Cartier, N ^a   Miclea J M ^b   Chomienne, C ^b   Bougneres P F ^a   Aubourg, P ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SATURATED FATTY ACID; VIRUS VECTOR;

ADRENOLEUKODYSTROPHY; ADULT; BONE MARROW TRANSPLANTATION; BRAIN; CHILD; CONFERENCE PAPER; DIET; GENE THERAPY; GENE TRANSFER; GENETIC DISORDER; HUMAN; KIDNEY; MALE; MORTALITY; PROGNOSIS; X CHROMOSOME LINKED DISORDER; METABOLISM; REVIEW;

ADRENOLEUKODYSTROPHY; BONE MARROW TRANSPLANTATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS;

EID: 0029938727     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0929-693x(96)85998-7     Document Type: Article

References (18)

1. Aubourg P. The leukodystrophies : A window to myelin. Nature Genes 1993;5:105-6
2. Moser HW, Smith KD, Moser AB. X-linked adrenoleukodystrophy. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited diseases. New-York: McGraw-Hill, 1995:2325-49
3. Mosser J, Douar AM, Sarde CO et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993;361:726-30
4. Higgins C. The ABC of channel regulation. Cell 1995;82:693-6
5. Mosser J, Lutz Y, Stoeckel ME et al. The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum Mol Genet 1994;3:265-71
6. Fanen P, Guidoux S, Sarde C O, Mandel J L, Goossens M, Aubourg P. Identification of mutations in the putative ATP-binding domain of the adrenoleukodystrophy gene. J Clin Invest 1994;94:516-20
7. Ligtenberg MJL, Kemp S, Sarde CO et al. Spectrum of mutations in the gene encoding the adrenoleukodystrophy protein. Am J Hum Genet 1995;56:44-50
8. Rizzo WB, Leshner RT, Odone A. Dietary erucic acid therapy for X-linked adrenoleukodystrophy. Neurology 1989;39:1415-22
9. Aubourg P, Adamsbaum C, Lavallard-Rousseau MC et al. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy. N Engl J Med. 1993;329:745-52
10. Friedmann T. Gene therapy for neurological disorders. Trends Genet 1994;10:210-4
11. Gage FH, Kawaja MD, Fisher LJ. Genetically modified cells: applications for intracerebral grafting. Trends Neurosci 1991; 14:328-33
12. Hickey WF, Kimura H. Perivascular microglial cells of the CNS are bone-marrow derived and present antigen in vivo. Science 1988;239:290-2
13. Aubourg P, Blanche S, Jambaque I et al. Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med 1990;322:1860-6
14. Krivit W, Shapiro E. Bone marrow transplantation for storage diseases. In: Desnick RJ, ed. Treatment of Genetics Diseases. New-York: Churchill-Livingstone, 1991:203-21
15. Kohn DB, Weinberg KI, Nolta JA et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Med 1995;1:1017-23
16. Carrier N, Lopez J, Moullier P et al. Retroviral-mediated gene transfer corrects very-long-chain fatty acid metabolism in adrenoleukodystrophy fibroblasts. Proc Natl Acad Sci USA 1995;92: 1674-8
17. Walsh CE, Nienhuis AW, Samulski RJ et al. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J Clin Invest 1994;94: 1440-8
18. Kasahara N, Dozy AM, Kan YW. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 1994;266:1373-5